Please login to the form below

Not currently logged in

People, September, 2008

Recent high-profile moves in the pharmaceutical and healthcare industries Mover of the month is John Dawson who has been appointed as acting chief executive of UK biotech firm Oxford BioMedica.

Mover of the month

John Dawson 

John Dawson has been appointed as acting chief executive of UK biotech firm Oxford BioMedica, following his appointment as a non-executive director in July 2008. John was previously at Cephalon for 11 years, where he held senior management positions including a management board position as chief financial officer and head of business development Europe. Prior to joining Oxford BioMedica, John was senior vice president corporate strategy at Scottish biotech Ardana. He replaces Mike McDonald.



Datapharm has appointed Lawrence (Larry) Berry as chief executive officer. Larry joins from the Centre for Medicines Research (CMR) International where he developed a range of innovative business propositions for CMR's pharma clients in the fields of R&D productivity and pipeline performance and risk management. Larry was previously a partner with Accenture, working with top UK FTSE 100 companies.

Ron Long has been appointed as non-executive director by DxS, the personalised medicine company. He has 40 years' experience in the sector and worked with the Wellcome Foundation for over 22 years, holding divisional director appointments in Wellcome Biotechnology and Coopers Animal Health. He was group managing director of Calmic International before leaving Wellcome in 1990. Ron joined Amersham as commercial director, eventually serving as CEO for Amersham Pharmacia Biotech and vice chairman of Amersham before retiring from the company in June 2001. He holds a number of other board positions at companies including Medivir AB, and Procognia Israel and previously held positions at Biacore, Kudos Pharmaceuticals, The Automation Partnership and Pharmagene/Asterand.

Allison Bartlett is joining Ketchum London's corporate and public affairs team as an associate director. She was previously head of government affairs at the Association of the British Pharmaceutical Industry (ABPI). Most recently, she was at the heart of making the industry case in the latest round of pricing renegotiations with government. She also worked for public affairs consultancy, Westminster Strategy, after jobs in the European Commission and a Washington DC–based trade association.

Margaret Meldrum has joined Spink's consumer healthcare team as director. She has over 10 years' marketing experience and was responsible for leading consumer healthcare brands such as Nicotinell, Voltarol, Tixylix, Listerine and Calpol for Novartis, Pfizer and Warner Lambert. In her new role, Margaret will provide strategic direction for existing and new clients, as well as focus on growing the agency's client portfolio and service offering (which includes brand planning and strategic consultancy) in the consumer healthcare sector.

Gillian Newbold has joined Healthcare Research Worldwide as associate director from Insight Research Group. She has over seven years' healthcare research experience on both the agency and client side. Gillian led a wide range of UK and international projects in areas such as market understanding, profile optimisation, branding and positioning.

John Young Communications has appointed Clayre Levitt as sales director to head up the company's new product launch The Ark.  During her 10 years in the pharmaceutical industry Clayre has worked in research management, service team management, sales management, marketing and NHS liaison across a number of therapy areas.  

Orchid has appointed Rebecca Porta as director of marketing. Rebecca will be responsible for developing and implementing Orchid's marketing and communications strategy with a focus on national media campaigns. She has over 17 year' experience working across a range of healthcare charities and has worked with the pharmaceutical industry to deliver campaigns in the areas of neurology, oncology and respiratory.

OgilvyHealthPR has made two new appointments to its team. Jenny O'Brien and Luke Willats both joined as account managers and will take on assignments for the agency's consumer and ethical healthcare clients. Jenny has worked for PR agencies, the government and as a health writer. For the past two years, she has focused on consumer marketing and media relations,  in the food, travel and lifestyle sectors. Previously she worked as a health promotions officer for local government and has written as a freelance writer for MSN Health. Luke has over three years' agency experience in consumer health and ethical PR and has worked across a broad range of disease areas including cardiovascular, oncology, COPD, nutrition and skin care. He has a degree in journalism from the University of Surrey and previously worked for a number of UK national newspapers, including the Daily Express.

Reynolds-MacKenzie (R-M) has appointed Tina Batchelor from Virgo Health PR as an associate director. She will be heading up a number of significant client accounts at R-M, including Roche's growing rheumatoid arthritis portfolio and Pfizer oncology. Tina has over ten years' experience in healthcare PR, having worked at Santé Communications and, more recently, Virgo Health PR. She has led both consumer and medical PR programmes for varying UK and international clients.

Alan Dorling has been appointed managing director of Commercial Consultancy – Unique Solutions for Pharma (USP). He previously worked for Bayer and Wyeth but more recently was European president of the STADA subsidiary Eurovax. Alan has worked across the UK pharma sector in primary and secondary care and has several years' experience in the UK generics market as managing director of Genus Pharmaceuticals. He was also principal consultant in strategic marketing for the Penn Group, focusing on the Life Science Sector. Rod Cameron also joins USP as account director and has over 10 years' experience in the pharma industry having worked in sales and training roles for a number of pharma firms, including AstraZeneca and Roche. More recently he was involved in late stage clinical research and development, spending several years as business development director, providing solutions and support to pharma clinical development teams.

Binley's has made changes to the senior management structure within its pharmaceutical business unit (PBU). Magda Lowthion, previously a PBU business development manager, has been appointed PBU commercial director and will head up the PBU account team. She has spent nearly 10 years' in the pharmaceutical industry in a variety of client-side business information and sales and marketing roles. Steve Bradley joins Binley's from Lundbeck where he held the position of head of business information and technology. He now assumes the role of PBU operations director to head up the CRM operations, technical services and specialist service teams. He also has 10 years' experience in the pharma industry and 15 years' in operations and general management. Andy Leeder becomes account director within the PBU account team to take on the leadership of enhancing Binley's CRM data services. Andy has over 25 years' experience in client services within the pharma industry. Binley's has also recruited two new senior analysts to join its CRM operations team, Ian Ervin and Tabi Peracha, as well as an additional business development executive and a business development assistant.

Alison Wilkie has joined Pharma Marketing Academy (PMA) as a senior marketing training consultant, leading brand strategy reviews, strategic marketing consultancy and marketing assessment centres projects. She has over 25 years' experience in the pharmaceutical industry, holding a number of senior roles in marketing at global and local level. Before joining PMA, Alison was a global brand insight director for a pre-launch brand at AstraZeneca.

The Rx Division at Euro RSCG Life UK has appointed four account handlers to its team. Account manager Reena Ondhia was previously at Seven Stones and Medicus, and senior account executive Amardeep Lally was previously at Lane, Earl and Cox. Account executive Clarissa De Marco also joins the team and account executive Cat Melo joins from Norris Lincoln.

Springer Healthcare Communications has made three new appointments to its team. Ryan Fitzpatrick has joined from Elysium as business development manager, Yasmin Ghariani has joined as a sales assistant from D'Events PR and Jon Roberts has joined as business development director from Wolters Kluwer Health.


Related links

FAQ: How do I get my move listed?


Subscribe to our email news alerts


Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....